These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12860230)

  • 1. Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary).
    Rajput FS; Gnanasekeram H; Satwani S; Davenport JD; Gracely EJ; Gopalan R; Narula J
    Am J Cardiol; 2003 Jul; 92(2):218-21. PubMed ID: 12860230
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.
    Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L
    Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?
    Doggrell SA
    Expert Opin Pharmacother; 2004 Jan; 5(1):205-8. PubMed ID: 14680448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
    Poole-Wilson PA; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Metra M; J Remme W; Swedberg K; Torp-Pedersen C
    Eur J Heart Fail; 2002 Jun; 4(3):321-9. PubMed ID: 12034158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In heart failure, all beta-blockers are not necessarily equal.
    Tang WH; Militello M; Francis GS
    Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blockers for heart failure.
    Cohn JN
    J Card Fail; 2003 Dec; 9(6):458. PubMed ID: 14966785
    [No Abstract]   [Full Text] [Related]  

  • 10. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 11. Carvedilol and metoprolol European trial: do the results merit challenge?
    Smith KM
    Am J Health Syst Pharm; 2004 Jun; 61(12):1289-93. PubMed ID: 15259762
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
    Ertl G; Nitschmann S
    Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol.
    Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS
    J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker therapy in heart failure: pathophysiology and clinical results.
    Carson PE
    Curr Probl Cardiol; 1999 Jul; 24(7):421-60. PubMed ID: 10403092
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
    J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
    Cleland JG
    Curr Heart Fail Rep; 2004 Jul; 1(2):82-8. PubMed ID: 16036030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AVID and COMET.
    Liebson PR; ;
    Prev Cardiol; 2003; 6(4):218-20. PubMed ID: 14605516
    [No Abstract]   [Full Text] [Related]  

  • 19. The COMET trial.
    Bristow MR; Adams KF; Bauman JL; Feldman AM; Giles TD; Goldstein S; Mann DL; Talbert RL
    Congest Heart Fail; 2005; 11(1):39-47. PubMed ID: 15722669
    [No Abstract]   [Full Text] [Related]  

  • 20. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.